See other indications for POMALYST:
This site is intended for US audiences only.
POMALYST is a prescription medicine, taken along with the medicine dexamethasone, used to treat adults with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.
Patients share their stories
about relapsed multiple myeloma
INSPIRING STORIES
Hear from other patients who continued their
journeys with their POMALYST® (pomalidomide) regimens.
LAURIE & NOWELL
Laurie and Nowell talk about their experience with POMALYST.
After you watch the video, learn more about how to take POMALYST.
Laurie is no longer taking POMALYST. This story is from one point along her journey.
Watch Video Fullscreen
:01 – On Screen Super: POMALYST (pomalidomide) is a prescription medicine, taken along with the medicine dexamethasone, used to treat people with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children. :10 – On Screen Super: POMALYST may cause serious side effects, including possible birth defects (deformed babies) or death of unborn baby, and blood clots in your arteries, veins, lungs, heart attack, and stroke. There are safety considerations to be aware of with POMALYST. That is why POMALYST is only available through a restricted distribution program, POMALYST REMS®. Please listen for Important Safety Information at the end of this video. :21 – Laurie: I want to set an example of being a warrior. I want my children to remember me as being strong and being a fighter. That’s really important to me. My name is Laurie and I’m from South Carolina. :35 – Nowell: And I’m Laurie’s husband Nowell. :38 – Laurie: My doctor did explain the possibility of relapse. That’s a very common possibility with multiple myeloma and it’s something that happens. :50 – Nowell: Relapses are tough because there always seems to be progress made and then there would be a relapse and so it was frustrating. But Laurie was always very good about digging into the details and educating herself. 1:04 – Laurie: You hear the diagnosis of an incurable cancer and people are always really stunned by that. But there is hope. On Screen Super: Laurie and Nowell were compensated for their time in the creation of this video. 1:14 – Nowell: It changed everything. The difficulties obviously are significant, but they pale in comparison to what changed in the way we loved each other. You know myeloma sucks but I’m the richest man in the world. 1:30 – Laurie: Well after I was diagnosed with multiple myeloma, I met with my doctor and we talked about different treatment options and so we worked to find what was suited for me. And that was REVLIMID and dexamethasone, so that was the beginning of my treatment. So, I continued with that for a while and then I did a proteasome inhibitor and then after I had relapsed, we tried the POMALYST and dexamethasone. That was his recommendation to move forward for treatment options. So, my experience with POMALYST has been positive. I like that it was an oral capsule. On Screen Super: Individual results with POMALYST will vary. 2:07 – Laurie: One of the more significant side effects was fatigue and GI issues. Everybody’s different and everybody responds differently but that was just how that affected my body. On Screen Super: Individual results with POMALYST will vary. Always consult your doctor about any side effects. 2:16 – Laurie: To remember to stay on treatment, I would set an alarm and that helped me to remember. Sometimes when you’re taking different medications it’s hard to keep track of everything. So, I would get my POMALYST prescription from my doctor and he would submit that to the specialty pharmacy and then I would do a REMS survey each month. 2:33 – Laurie: What kept me motivated after my relapse was my family. It was wanting to be there to have time with Nowell and with my grandchildren. That’s so important to me and such a huge part of my life and that really was so important that I wanted to fight, I wanted to stay in the battle. Because it is a battle and I remember my doctor saying that to me when I was diagnosed and that really helped me. 2:56 – Nowell: I am so proud of you for fighting this fight, for being the love of my life, for teaching me what life is really all about. And that you fight and that you do it with a smile on your face and with a tender heart. It’s just lovely and I love you for it. 3:13 – Laurie: Well, you make fighting for very easy. It’s a gift. It’s a gift. 3:25 – 13:00: Indication VO:
Important Safety Information
What is POMALYST® (pomalidomide)?
POMALYST is a prescription medicine, taken along with the medicine dexamethasone, used to treat adults with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.
WARNINGS: Risk to unborn babies, and blood clots.
What is the most important information I should know about POMALYST?
Before you begin taking POMALYST, you must read and agree to all of the instructions in the POMALYST REMS® program. Before prescribing POMALYST, your healthcare provider (HCP) will explain the POMALYST REMS program to you and have you sign the Patient-Physician Agreement Form.
POMALYST can cause serious side effects, including:
- Possible birth defects (deformed babies) or death of an unborn baby. Females who are pregnant or plan to become pregnant must not take POMALYST.
- POMALYST is similar to the medicine thalidomide (THALOMID®), which is known to cause severe life-threatening birth defects. POMALYST has not been tested in pregnant females. POMALYST has harmed unborn animals in animal testing.
- Females must not get pregnant:
- For at least 4 weeks before starting POMALYST
- While taking POMALYST
- During any breaks (interruptions) in your treatment with POMALYST
- For at least 4 weeks after stopping POMALYST
- Females who can become pregnant:
- Will have pregnancy tests weekly for 4 weeks, then every 4 weeks if your menstrual cycle is regular, or every 2 weeks if your menstrual cycle is irregular.
If you miss your period or have unusual bleeding, you will need to have a pregnancy test and receive counseling. - Must agree to use 2 acceptable forms of effective birth control at the same time, for at least 4 weeks before, while taking, during any breaks (interruptions) in treatment, and for at least 4 weeks after stopping POMALYST.
- Talk with your healthcare provider to find out about options for acceptable forms of birth control that you may use to prevent pregnancy during and after treatment with POMALYST.
- Will have pregnancy tests weekly for 4 weeks, then every 4 weeks if your menstrual cycle is regular, or every 2 weeks if your menstrual cycle is irregular.
- If you become pregnant while taking POMALYST, stop taking it right away and call your healthcare provider. If your healthcare provider is not available, you can call Celgene Customer Care Center at 1-888-423-5436. Healthcare providers and patients should report all cases of pregnancy to:
- FDA MedWatch at 1-800-FDA-1088
- Celgene Corporation at 1-888-423-5436
- POMALYST can pass into human semen:
- Males, including those who have had a vasectomy, must always use a latex or synthetic condom during any sexual contact with a pregnant female or a female that can become pregnant while taking POMALYST, during any breaks (interruptions) in your treatment with POMALYST, and for 4 weeks after stopping POMALYST.
- Do not have unprotected sexual contact with a female who is or could become pregnant. Tell your healthcare provider if you do have unprotected sexual contact with a female who is or could become pregnant.
- Do not donate sperm while taking POMALYST, during any breaks (interruptions) in your treatment, and for 4 weeks after stopping POMALYST. If a female becomes pregnant with your sperm, the baby may be exposed to POMALYST and may be born with birth defects.
- Do not donate blood while you take POMALYST, during any breaks (interruptions) in your treatment, and for 4 weeks after stopping POMALYST. If someone who is pregnant gets your donated blood, her baby may be exposed to POMALYST and may be born with birth defects.
There is a pregnancy exposure registry that monitors the outcomes of females who take POMALYST during pregnancy, or if their male partner takes POMALYST and they are exposed during pregnancy. You can enroll in this registry by calling Celgene Corporation at the phone number listed above.
Men, if your female partner becomes pregnant, you should call your healthcare provider right away.
- Blood clots in your arteries, veins, and lungs, heart attack, and stroke can happen if you take POMALYST.
- Most people who take POMALYST will also take a blood thinner medicine to help prevent blood clots.
- Before taking POMALYST, tell your healthcare provider:
- If you have had a blood clot in the past.
- If you have high blood pressure, smoke, or if you have been told you have a high level of fat in your blood (hyperlipidemia).
- About all the medicines you take. Certain other medicines can also increase your risk for blood clots.
Call your healthcare provider or get medical help right away if you get any of the following during treatment with POMALYST:
- Signs or symptoms of a blood clot in the lung, arm, or leg may include: shortness of breath, chest pain, or arm or leg swelling.
- Signs or symptoms of a heart attack may include: chest pain that may spread to the arms, neck, jaw, back, or stomach area (abdomen); feeling sweaty, shortness of breath, feeling sick, or vomiting.
- Signs or symptoms of stroke may include: sudden numbness or weakness, especially on one side of the body, severe headache or confusion, or problems with vision, speech, or balance.
- A red, itchy skin rash
- Peeling of your skin or blisters
- Severe itching
- Fever
Get emergency medical help right away if you develop any of the following signs or symptoms during treatment with POMALYST:
- swelling of your lips, mouth, tongue, or throat
- trouble breathing or swallowing
- raised red areas on your skin (hives)
- a very fast heartbeat
- you feel dizzy or faint
Who should not take POMALYST?
Do not take POMALYST if you:
- Are pregnant, plan to become pregnant, or become pregnant during treatment with POMALYST. See “What is the most important information I should know about POMALYST?”
- Are allergic to pomalidomide or any of the ingredients in POMALYST.
What should I tell my healthcare provider (HCP) before taking POMALYST?
- If you smoke cigarettes (POMALYST may not work as well in people who smoke), have any other medical conditions, or are breastfeeding. Do not breastfeed during treatment with POMALYST—it is not known if POMALYST passes into breast milk and can harm the baby.
- If you have liver problems
- If you have kidney problems and are receiving hemodialysis treatment
- Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. POMALYST and other medicines may affect each other, causing serious side effects. Talk with your HCP before taking any new medicines.
How should I take POMALYST?
Take POMALYST exactly as prescribed and follow all the instructions of the POMALYST REMS program.
- Swallow POMALYST capsules whole with water 1 time a day. Do not break, chew, or open capsules.
- Take POMALYST at the same time each day with or without food.
- If you are on hemodialysis, take POMALYST after hemodialysis on hemodialysis days.
- Do not open POMALYST capsules or handle them any more than needed. If you touch a broken POMALYST capsule or the medicine in the capsule, wash the area of your body right away with soap and water.
- If you miss a dose of POMALYST and it has been less than 12 hours since your regular time, take POMALYST as soon as you remember. If it has been more than 12 hours, just skip your missed dose. Do not take 2 doses at the same time.
- If you take too much POMALYST, call your healthcare provider (HCP) right away.
- Do not share POMALYST with other people. It may cause birth defects and other serious problems.
What are the possible side effects of POMALYST?
- See “What is the most important information I should know about POMALYST?”
- POMALYST can cause serious side effects, including:
- Low white blood cells (neutropenia), low platelets (thrombocytopenia), and low red blood cells (anemia) are common with POMALYST, but can also be serious. You may need a blood transfusion or certain medicines if your blood counts drop too low. Your blood counts should be checked by your healthcare provider (HCP) weekly for the first 8 weeks of treatment and monthly after that.
- Severe liver problems, including liver failure and death. Your HCP should do blood tests to check your liver function during your treatment with POMALYST. Tell your HCP right away if you develop any of the following symptoms: yellowing of your skin or the white parts of your eyes (jaundice); dark or brown (tea-colored) urine; pain on the upper right side of your stomach area (abdomen); bleeding or bruising more easily than normal, or feeling very tired.
- Severe allergic and severe skin reactions can happen with POMALYST and may cause death.
- Dizziness and confusion. Avoid taking other medicines that may cause dizziness and confusion during treatment with POMALYST. Avoid situations that require you to be alert until you know how POMALYST affects you.
- Nerve damage. Stop taking POMALYST and call your HCP if you develop numbness, tingling, pain, or a burning sensation in your hands, legs, or feet.
- New cancers (malignancies). New cancers, including certain blood cancers (acute myelogenous leukemia or AML) have been seen in people who received POMALYST. Talk with your HCP about your risk.
- Tumor Lysis Syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure and the need for dialysis treatment, abnormal heart rhythm, seizure, and sometimes death. Your HCP may do blood tests to check you for TLS.
- The most common side effects of POMALYST include tiredness and weakness, constipation, nausea, diarrhea, shortness of breath, upper respiratory tract infection, back pain, and fever.
- These are not all the possible side effects of POMALYST. Your HCP may tell you to stop taking POMALYST if you develop certain serious side effects during treatment. Call your HCP for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide.
POMALYST® and POMALYST REMS® are registered trademarks of Celgene Corporation, a Bristol Myers Squibb company.
© 2022 Bristol-Myers Squibb Company 04/22 2204-US-2200046
Laurie and Nowell talk about their experience with POMALYST.
After you watch the video, learn more about how to take POMALYST.
Laurie is no longer taking POMALYST. This story is from one point along her journey.
MARC & MICHELE
Marc and Michele share how both POMALYST and a sense of humor played a role after Marc’s relapse.
After you watch the video, learn more about
relapse.
Marc is currently taking POMALYST.
Watch Video Fullscreen
:01 – On Screen Super: POMALYST (pomalidomide) is a prescription medicine, taken along with the medicine dexamethasone, used to treat people with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children. :10 – On Screen Super: POMALYST may cause serious side effects, including possible birth defects (deformed babies) or death of unborn baby, and blood clots in your arteries, veins, lungs, heart attack, and stroke. There are safety considerations to be aware of with POMALYST. That is why POMALYST is only available through a restricted distribution program, POMALYST REMS®. Please listen for Important Safety Information at the end of this video. :18 – Marc: It was surreal when I was told that I had multiple myeloma. It just shocked me. I was fit, healthy, active and that diagnosis changed my whole career from law enforcement and firefighting into fighting the multiple myeloma. :40 – Marc: My name is Marc; I’m married to Michele. When I was told I was relapsing my mind initially started going, “oh my god, you know what options do I have?” It was unexpected. On Screen Super: Marc and Michelle were compensated for their time in the creation of this video. :59 – Michele: I’m an emotional person as you can tell. It was scary, it was very scary. 1:11 – Marc: My treatment plan included, REVLIMID with dex. A proteasome inhibitor. After I relapsed, my doctor put me on POMALYST with dexamethasone. He felt that was the way for us to fight the multiple myeloma. On Screen Super: The REVLIMID and dexamethasone regimen was followed by a separate regimen including a proteasome inhibitor in Marc’s treatment. 1:24 – Marc: I like POMALYST for the fact that it’s an oral medication and it fits well within my lifestyle. I typically take it after my meal so I’m taking it at the same time, I just take it when I’m done eating dinner. On Screen Super: Individual results with POMALYST will vary. 1:38 – Marc: When I started taking POMALYST, I had a side effect of rash. I spoke to my doctor about it. He is absolutely phenomenal. He’s there for me, even if I don’t have an appointment. I can call him up and say, “hey here’s the problem I have” and his nurse is on it. On Screen Super: Individual results with POMALYST will vary. Call your HCP if you have any symptoms of an allergic reaction, including swelling of your lips, mouth, tongue, or throat; trouble breathing; or skin reaction. 1:56 – Marc: So, what keeps me motivated through all of this and staying on treatment is my family. My wife and my daughter. Michele took on the role of caregiver unwilling; it was thrust upon her. But she has been amazing with it. Always wanting to be there when I’m going through treatment and always being there. 2:17 – Michele: Don’t do it alone. Let people help you, they want to help you, your neighbors want to help you. 2:24 – Marc: I’ve always liked to laugh. Even growing up trying to take bad things and interject some humor and I never really realized the importance until I became sick. 2:38 – Michele: I believe what you put out is what you get back. So, I try to be positive. 2:45 – Marc: You do a good job at that. 2:48 – Michele: I do. The advice I would give to someone just starting to be a caregiver is to take care of yourself also. Don’t get so wrapped up in taking care of someone else that you forget about yourself. 3:02 – Marc: Instead of worrying about the big overall picture, little piece at a time. You have to be tougher than the disease and I’m not going to let the disease win. I have a wife and a daughter. I have a life and I’m not going to let a disease take over me and make me somebody I’m not. 3:24 – 13:02: Indication VO:
Important Safety Information
What is POMALYST® (pomalidomide)?
POMALYST is a prescription medicine, taken along with the medicine dexamethasone, used to treat adults with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.
WARNINGS: Risk to unborn babies, and blood clots.
What is the most important information I should know about POMALYST?
Before you begin taking POMALYST, you must read and agree to all of the instructions in the POMALYST REMS® program. Before prescribing POMALYST, your healthcare provider (HCP) will explain the POMALYST REMS program to you and have you sign the Patient-Physician Agreement Form.
POMALYST can cause serious side effects, including:
- Possible birth defects (deformed babies) or death of an unborn baby. Females who are pregnant or plan to become pregnant must not take POMALYST.
- POMALYST is similar to the medicine thalidomide (THALOMID®), which is known to cause severe life-threatening birth defects. POMALYST has not been tested in pregnant females. POMALYST has harmed unborn animals in animal testing.
- Females must not get pregnant:
- For at least 4 weeks before starting POMALYST
- While taking POMALYST
- During any breaks (interruptions) in your treatment with POMALYST
- For at least 4 weeks after stopping POMALYST
- Females who can become pregnant:
- Will have pregnancy tests weekly for 4 weeks, then every 4 weeks if your menstrual cycle is regular, or every 2 weeks if your menstrual cycle is irregular.
If you miss your period or have unusual bleeding, you will need to have a pregnancy test and receive counseling. - Must agree to use 2 acceptable forms of effective birth control at the same time, for at least 4 weeks before, while taking, during any breaks (interruptions) in treatment, and for at least 4 weeks after stopping POMALYST.
- Talk with your healthcare provider to find out about options for acceptable forms of birth control that you may use to prevent pregnancy during and after treatment with POMALYST.
- Will have pregnancy tests weekly for 4 weeks, then every 4 weeks if your menstrual cycle is regular, or every 2 weeks if your menstrual cycle is irregular.
- If you become pregnant while taking POMALYST, stop taking it right away and call your healthcare provider. If your healthcare provider is not available, you can call Celgene Customer Care Center at 1-888-423-5436. Healthcare providers and patients should report all cases of pregnancy to:
- FDA MedWatch at 1-800-FDA-1088
- Celgene Corporation at 1-888-423-5436
- POMALYST can pass into human semen:
- Males, including those who have had a vasectomy, must always use a latex or synthetic condom during any sexual contact with a pregnant female or a female that can become pregnant while taking POMALYST, during any breaks (interruptions) in your treatment with POMALYST, and for 4 weeks after stopping POMALYST.
- Do not have unprotected sexual contact with a female who is or could become pregnant. Tell your healthcare provider if you do have unprotected sexual contact with a female who is or could become pregnant.
- Do not donate sperm while taking POMALYST, during any breaks (interruptions) in your treatment, and for 4 weeks after stopping POMALYST. If a female becomes pregnant with your sperm, the baby may be exposed to POMALYST and may be born with birth defects.
- Do not donate blood while you take POMALYST, during any breaks (interruptions) in your treatment, and for 4 weeks after stopping POMALYST. If someone who is pregnant gets your donated blood, her baby may be exposed to POMALYST and may be born with birth defects.
There is a pregnancy exposure registry that monitors the outcomes of females who take POMALYST during pregnancy, or if their male partner takes POMALYST and they are exposed during pregnancy. You can enroll in this registry by calling Celgene Corporation at the phone number listed above.
Men, if your female partner becomes pregnant, you should call your healthcare provider right away.
- Blood clots in your arteries, veins, and lungs, heart attack, and stroke can happen if you take POMALYST.
- Most people who take POMALYST will also take a blood thinner medicine to help prevent blood clots.
- Before taking POMALYST, tell your healthcare provider:
- If you have had a blood clot in the past.
- If you have high blood pressure, smoke, or if you have been told you have a high level of fat in your blood (hyperlipidemia).
- About all the medicines you take. Certain other medicines can also increase your risk for blood clots.
Call your healthcare provider or get medical help right away if you get any of the following during treatment with POMALYST:
- Signs or symptoms of a blood clot in the lung, arm, or leg may include: shortness of breath, chest pain, or arm or leg swelling.
- Signs or symptoms of a heart attack may include: chest pain that may spread to the arms, neck, jaw, back, or stomach area (abdomen); feeling sweaty, shortness of breath, feeling sick, or vomiting.
- Signs or symptoms of stroke may include: sudden numbness or weakness, especially on one side of the body, severe headache or confusion, or problems with vision, speech, or balance.
- A red, itchy skin rash
- Peeling of your skin or blisters
- Severe itching
- Fever
Get emergency medical help right away if you develop any of the following signs or symptoms during treatment with POMALYST:
- swelling of your lips, mouth, tongue, or throat
- trouble breathing or swallowing
- raised red areas on your skin (hives)
- a very fast heartbeat
- you feel dizzy or faint
Who should not take POMALYST?
Do not take POMALYST if you:
- Are pregnant, plan to become pregnant, or become pregnant during treatment with POMALYST. See “What is the most important information I should know about POMALYST?”
- Are allergic to pomalidomide or any of the ingredients in POMALYST.
What should I tell my healthcare provider (HCP) before taking POMALYST?
- If you smoke cigarettes (POMALYST may not work as well in people who smoke), have any other medical conditions, or are breastfeeding. Do not breastfeed during treatment with POMALYST—it is not known if POMALYST passes into breast milk and can harm the baby.
- If you have liver problems
- If you have kidney problems and are receiving hemodialysis treatment
- Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. POMALYST and other medicines may affect each other, causing serious side effects. Talk with your HCP before taking any new medicines.
How should I take POMALYST?
Take POMALYST exactly as prescribed and follow all the instructions of the POMALYST REMS program.
- Swallow POMALYST capsules whole with water 1 time a day. Do not break, chew, or open capsules.
- Take POMALYST at the same time each day with or without food.
- If you are on hemodialysis, take POMALYST after hemodialysis on hemodialysis days.
- Do not open POMALYST capsules or handle them any more than needed. If you touch a broken POMALYST capsule or the medicine in the capsule, wash the area of your body right away with soap and water.
- If you miss a dose of POMALYST and it has been less than 12 hours since your regular time, take POMALYST as soon as you remember. If it has been more than 12 hours, just skip your missed dose. Do not take 2 doses at the same time.
- If you take too much POMALYST, call your healthcare provider (HCP) right away.
- Do not share POMALYST with other people. It may cause birth defects and other serious problems.
What are the possible side effects of POMALYST?
- See “What is the most important information I should know about POMALYST?”
- POMALYST can cause serious side effects, including:
- Low white blood cells (neutropenia), low platelets (thrombocytopenia), and low red blood cells (anemia) are common with POMALYST, but can also be serious. You may need a blood transfusion or certain medicines if your blood counts drop too low. Your blood counts should be checked by your healthcare provider (HCP) weekly for the first 8 weeks of treatment and monthly after that.
- Severe liver problems, including liver failure and death. Your HCP should do blood tests to check your liver function during your treatment with POMALYST. Tell your HCP right away if you develop any of the following symptoms: yellowing of your skin or the white parts of your eyes (jaundice); dark or brown (tea-colored) urine; pain on the upper right side of your stomach area (abdomen); bleeding or bruising more easily than normal, or feeling very tired.
- Severe allergic and severe skin reactions can happen with POMALYST and may cause death.
- Dizziness and confusion. Avoid taking other medicines that may cause dizziness and confusion during treatment with POMALYST. Avoid situations that require you to be alert until you know how POMALYST affects you.
- Nerve damage. Stop taking POMALYST and call your HCP if you develop numbness, tingling, pain, or a burning sensation in your hands, legs, or feet.
- New cancers (malignancies). New cancers, including certain blood cancers (acute myelogenous leukemia or AML) have been seen in people who received POMALYST. Talk with your HCP about your risk.
- Tumor Lysis Syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure and the need for dialysis treatment, abnormal heart rhythm, seizure, and sometimes death. Your HCP may do blood tests to check you for TLS.
- The most common side effects of POMALYST include tiredness and weakness, constipation, nausea, diarrhea, shortness of breath, upper respiratory tract infection, back pain, and fever.
- These are not all the possible side effects of POMALYST. Your HCP may tell you to stop taking POMALYST if you develop certain serious side effects during treatment. Call your HCP for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide.
POMALYST® and POMALYST REMS® are registered trademarks of Celgene Corporation, a Bristol Myers Squibb company.
© 2020 Bristol-Myers Squibb Company 11/20 US-POM-20-0395
Marc and Michele share how both POMALYST and a sense of humor played a role after Marc’s relapse.
After you watch the video, learn more about relapse.
Marc is currently taking POMALYST.
Laurie, Nowell, Marc, and Michele were compensated for their time by Celgene Corporation, a Bristol Myers Squibb company.
Join the My Momentum program to receive information and resources that may help you along your multiple myeloma journey.
Sign Up Now
This website is best viewed
using the horizontal display
on your tablet device.
This website is best viewed
using the vertical display
on your mobile device.